Literature DB >> 26066729

Applying the ethoexperimental approach to neurodevelopmental syndrome research reveals exaggerated defensive behavior in Mecp2 mutant mice.

Brandon L Pearson, Erwin B Defensor, D Caroline Blanchard, Robert J Blanchard.   

Abstract

Rett syndrome is a Pervasive Developmental Disorder (PDD) associated with de novo mutations of the methyl CpG-binding protein 2 (MECP2) gene. Mecp2 functions as a transcription factor that regulates the expression of hundreds of genes. Identification of the role of Mecp2 in specific neurodevelopmental symptoms remains an important research aim. We previously demonstrated that male mice possessing a truncation mutation in Mecp2 are hyper-social. We predicted that reduced fear or anxiety might underlie this enhanced affiliation. In order to probe risk assessment and anxiety-like behavior, we compared Mecp2 truncation mutants to their wild-type littermates in the elevated plus maze and elevated zero maze. Additionally, subjects were administered the mouse defense test battery to evaluate unconditioned fear- and panic-like behavior to a graded set of threat scenarios and a predator stimulus. Mutant mice showed no significant changes in anxiety-like behavior. Yet, they displayed hyper-reactive escape and defensive behaviors to an animate predatory threat stimulus. Notably, mutant mice engaged in exaggerated active defense responding to threat stimuli at nearly all phases of the fear battery. These results reveal abnormalities in emotion regulation in Mecp2 mutants particularly in response to ecologically relevant threats. This hyper-responsivity suggests that transcriptional targets of Mecp2 are critical to emotion regulation. Moreover, we suggest that detailed analysis of defensive behavior and aggression with ethologically relevant tasks provides an avenue to interrogate gene-behavior mechanisms of neurodevelopmental and other psychiatric conditions.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26066729      PMCID: PMC4584164          DOI: 10.1016/j.physbeh.2015.03.035

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  70 in total

1.  Loss of Mecp2 in substantia nigra dopamine neurons compromises the nigrostriatal pathway.

Authors:  Stephanie C Gantz; Christopher P Ford; Kim A Neve; John T Williams
Journal:  J Neurosci       Date:  2011-08-31       Impact factor: 6.167

2.  Mutation of MeCP2 alters transcriptional regulation of select immediate-early genes.

Authors:  Dan Su; Young May Cha; Anne E West
Journal:  Epigenetics       Date:  2012-02       Impact factor: 4.528

3.  Modification of Mecp2 dosage alters axonal transport through the Huntingtin/Hap1 pathway.

Authors:  Jean-Christophe Roux; Diana Zala; Nicolas Panayotis; Ana Borges-Correia; Frédéric Saudou; Laurent Villard
Journal:  Neurobiol Dis       Date:  2011-11-15       Impact factor: 5.996

4.  Mecp2 truncation in male mice promotes affiliative social behavior.

Authors:  B L Pearson; E B Defensor; R L H Pobbe; L H L Yamamoto; V J Bolivar; D C Blanchard; R J Blanchard
Journal:  Behav Genet       Date:  2011-09-11       Impact factor: 2.805

5.  Behavioral and anatomical abnormalities in Mecp2 mutant mice: a model for Rett syndrome.

Authors:  N A Stearns; L R Schaevitz; H Bowling; N Nag; U V Berger; J Berger-Sweeney
Journal:  Neuroscience       Date:  2007-03-23       Impact factor: 3.590

Review 6.  Mouse models of Rett syndrome: from behavioural phenotyping to preclinical evaluation of new therapeutic approaches.

Authors:  Laura Ricceri; Bianca De Filippis; Giovanni Laviola
Journal:  Behav Pharmacol       Date:  2008-09       Impact factor: 2.293

7.  Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation.

Authors:  Raman P Nagarajan; Amber R Hogart; Ynnez Gwye; Michelle R Martin; Janine M LaSalle
Journal:  Epigenetics       Date:  2006 Oct-Dec       Impact factor: 4.528

8.  MeCP2 mutation results in compartment-specific reductions in dendritic branching and spine density in layer 5 motor cortical neurons of YFP-H mice.

Authors:  David P Stuss; Jamie D Boyd; David B Levin; Kerry R Delaney
Journal:  PLoS One       Date:  2012-03-07       Impact factor: 3.240

9.  Crh and Oprm1 mediate anxiety-related behavior and social approach in a mouse model of MECP2 duplication syndrome.

Authors:  Rodney C Samaco; Caleigh Mandel-Brehm; Christopher M McGraw; Chad A Shaw; Bryan E McGill; Huda Y Zoghbi
Journal:  Nat Genet       Date:  2012-01-08       Impact factor: 38.330

10.  MeCP2, a key contributor to neurological disease, activates and represses transcription.

Authors:  Maria Chahrour; Sung Yun Jung; Chad Shaw; Xiaobo Zhou; Stephen T C Wong; Jun Qin; Huda Y Zoghbi
Journal:  Science       Date:  2008-05-30       Impact factor: 47.728

View more
  5 in total

1.  MeCP2 deficiency results in robust Rett-like behavioural and motor deficits in male and female rats.

Authors:  Kelsey C Patterson; Virginia E Hawkins; Kara M Arps; Daniel K Mulkey; Michelle L Olsen
Journal:  Hum Mol Genet       Date:  2016-06-21       Impact factor: 6.150

2.  Behavior of Male and Female C57BL/6J Mice Is More Consistent with Repeated Trials in the Elevated Zero Maze than in the Elevated Plus Maze.

Authors:  Laura B Tucker; Joseph T McCabe
Journal:  Front Behav Neurosci       Date:  2017-01-26       Impact factor: 3.558

3.  Peripheral Mechanosensory Neuron Dysfunction Underlies Tactile and Behavioral Deficits in Mouse Models of ASDs.

Authors:  Lauren L Orefice; Amanda L Zimmerman; Anda M Chirila; Steven J Sleboda; Joshua P Head; David D Ginty
Journal:  Cell       Date:  2016-06-09       Impact factor: 41.582

4.  MATSAP: An automated analysis of stretch-attend posture in rodent behavioral experiments.

Authors:  Kevin S Holly; Casey O Orndorff; Teresa A Murray
Journal:  Sci Rep       Date:  2016-08-09       Impact factor: 4.379

5.  Protective role of mirtazapine in adult female Mecp2+/- mice and patients with Rett syndrome.

Authors:  Javier Flores Gutiérrez; Claudio De Felice; Giulia Natali; Silvia Leoncini; Cinzia Signorini; Joussef Hayek; Enrico Tongiorgi
Journal:  J Neurodev Disord       Date:  2020-09-28       Impact factor: 4.025

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.